Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
32 hedge funds and large institutions have $66.9M invested in Fibrocell Science Inc. in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 11 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.3% less ownership
Funds ownership: 64.67% → 63.37% (-1.3%)
16% less funds holding
Funds holding: 38 → 32 (-6)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
86% less capital inflows, than outflows
Capital inflows: $250K | Capital outflows: $1.74M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
+$130K |
| 2 |
Millennium Management
New York
|
+$43K |
| 3 |
Catalyst Capital Advisors
Huntington,
New York
|
+$16.2K |
| 4 |
BlackRock Fund Advisors
San Francisco,
California
|
+$13.8K |
| 5 |
BlackRock Japan
Tokyo,
Japan
|
+$8.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$601K |
| 2 |
Franklin Street Advisors
Chapel Hill,
North Carolina
|
-$268K |
| 3 |
Bridgeway Capital Management
Houston,
Texas
|
-$263K |
| 4 |
Jennison Associates
New York
|
-$229K |
| 5 |
BlackRock Institutional Trust
San Francisco,
California
|
-$84.2K |
FCSC Hedge Fund Activity: Q4 2014 in Review
32 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2014, worth a combined $66.9M — down 13% from $76.6M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of FCSC and 6 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Stoneridge Investment Partners, adding an estimated $130K. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $601K sold.
- 32 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2014, down from 38 in Q3 2014.
- Funds reported $66.9M of Fibrocell Science Inc. stock for Q4 2014, down 13% quarter-over-quarter.
- 6 funds opened new Fibrocell Science Inc. positions in Q4 2014 and 11 closed out, a net change of -5 holders.
- The largest Fibrocell Science Inc. buyer in Q4 2014 was Stoneridge Investment Partners, an estimated $130K added.
- The largest Fibrocell Science Inc. seller in Q4 2014 was Cambridge Investment Research Advisors, an estimated $601K sold.
Based on aggregated 13F filings for Q4 2014.